2020 China New Design Lorcaserin Hydrochloride - High Purity 366789-02-8 Rivaroxaban for Treatment of Adult Venous Thrombosis – Yibai
2020 China New Design Lorcaserin Hydrochloride - High Purity 366789-02-8 Rivaroxaban for Treatment of Adult Venous Thrombosis – Yibai Detail:
Product name | Rivaroxaban |
Synonyms | 5-Chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide |
CAS No. | 366789-02-8 |
Appearance | White powder |
Molecular Formula | C19H18ClN3O5S |
Molecular Weight | 435.88 |
Application | Pharmaceutical grade or research purpose |
Packing | As per your request |
Storage | Preserve in tight,light-resistant containers in a cool place |
Company Information
√ Management layer’s full experience in factory and skilled technicians followers; √ Quality is always our top consideration, Strict QC system; √ 11 years experienced exporting sales team; √ Independent R&D lab; √ Two signed long term GMP workshops; √ Rich resources of plenty idle factories for customized project; √ High Efficiency working team with consistent path.Product detail pictures:
Related Product Guide:
As for competitive charges, we believe that you will be searching far and wide for anything that can beat us. We will state with absolute certainty that for such excellent at such charges we have been the lowest around for 2020 China New Design Lorcaserin Hydrochloride - High Purity 366789-02-8 Rivaroxaban for Treatment of Adult Venous Thrombosis – Yibai , The product will supply to all over the world, such as: Seychelles, Sweden, Portugal, We are committed to meet all your needs and solve any technical problems you may encounter with your industrial components. Our exceptional products and vast knowledge of technology makes us the preferred choice for our customers.
By Susan from Chicago - 2017.04.08 14:55
Wide range, good quality, reasonable prices and good service, advanced equipment, excellent talents and continuously strengthened technology forces,a nice business partner.
By Michelle from Lithuania - 2018.06.12 16:22
Write your message here and send it to us